Ledger.Open graph →
SEC Form D · Amendment · filed April 17, 2015

BioAegis Therapeutics, Inc

Offering
—
Sold
$8.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MORRISTOWN, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Susan Levinson · Morristown, NJExec · DirectorValerie Ceva · Morristown, NJExec · DirectorThomas Stossel · Morristown, NJDirectorSteve Cordovano · Morristown, NJExecJames A. Rogers · ANCHORAGE, AKExecRichard Slaughter · San Diego, CADirectorCharles B. Krusen · NEW YORK, NYExec · DirectorNicholas D. Smith · SEBASTOPOL, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗